rs863224999
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_004006.3(DMD):c.4729C>T(p.Arg1577*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_004006.3 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DMD | ENST00000357033.9 | c.4729C>T | p.Arg1577* | stop_gained | Exon 34 of 79 | 1 | NM_004006.3 | ENSP00000354923.3 |
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD4 exome Cov.: 29
GnomAD4 genome Cov.: 22
ClinVar
Submissions by phenotype
not provided Pathogenic:4
Not observed at significant frequency in large population cohorts (gnomAD); Nonsense variant predicted to result in nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Based on the understanding of this genetic alteration, it may be amenable to nonsense read-through therapy that is currently available or in clinical trial; This variant is associated with the following publications: (PMID: 19783145, 21515508, 21972111, 28503591, 12233050, 20485447, 19937601, 25525159, 23453023, 18652600, 26110187, 28332368, 28318817, 31412794, 32559196, 34297739, 34925456) -
The variant creates a premature nonsense codon, and is therefore predicted to result in the loss of a functional protein. Found in at least one patient with expected phenotype for this gene, and not found in general population data. -
- -
- -
Duchenne muscular dystrophy Pathogenic:2
PVS1, PM2, PP5 -
This sequence change creates a premature translational stop signal (p.Arg1577*) in the DMD gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DMD are known to be pathogenic (PMID: 16770791, 25007885). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individuals with Duchenne muscular dystrophy (PMID: 18652600, 19783145, 20485447, 21515508, 23453023). ClinVar contains an entry for this variant (Variation ID: 217199). For these reasons, this variant has been classified as Pathogenic. -
Qualitative or quantitative defects of dystrophin Pathogenic:1
Variant summary: DMD c.4729C>T (p.Arg1577X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant was absent in 182057 control chromosomes (gnomAD). c.4729C>T has been reported in the literature in multiple individuals affected with Dystrophinopathies. Most of these individuals were affected with DMD (Duchenne Muscular Dystrophy)(e.g. Esterhuizen_2014, Flanigan_2011, Takeshima_2010) .These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Three ClinVar submitters (evaluation after 2014) cite the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -
Dilated cardiomyopathy 3B Pathogenic:1
- -
Cardiovascular phenotype Pathogenic:1
The p.R1577* pathogenic mutation (also known as c.4729C>T), located in coding exon 34 of the DMD gene, results from a C to T substitution at nucleotide position 4729. This changes the amino acid from an arginine to a stop codon within coding exon 34. This alteration has been reported in multiple individuals with Duchenne muscular dystrophy (DMD) (Takeshima Y et al. J. Hum. Genet., 2010 Jun;55:379-88; Sedlácková J et al. Neuromuscul. Disord., 2009 Nov;19:749-53; Yang J et al. BMC Med. Genet., 2013 Mar;14:29; Mah JK et al. Can J Neurol Sci, 2011 May;38:465-74; Suh MR et al. Yonsei Med. J., 2017 May;58:613-618; Vieitez I et al. Neurologia Mar;32:377-385; Kong X et al. BMC Med. Genet., 2019 08;20:139; Flanigan KM et al. Hum. Mutat., 2009 Dec;30:1657-66). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at